The European Medicines Agency (EMA) has started a review of Tavneos® (avacopan), a medicine used to treat ANCA-associated vasculitis, including GPA and MPA. This review is not due to new safety concerns or side …

The UKIVAS (United Kingdom & All Ireland Vasculitis Society) annual Vasculitis Education event was held in November 2025. It’s a two-day event open to those medical professionals with a special …

We ask you to support VUK and join our AGM online. It is important to register so that we can send you the link to join the meeting, the agenda …

The British Society for Rheumatology has published an updated evidence-based clinical guideline on the safe use of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) across the full spectrum of autoimmune rheumatic …

The Autumn 2025 Newsletter is now available online. Those registered to receive it by post should receive their copy within the next few days.

A new report from Kidney Research UK has exposed the shocking reality faced by people living with rare kidney diseases in the UK. The independent study, Collectively common: the devastating …

Takayasu Arteritis patients, and physicians treating them, are invited to take part in the TAK-IMPACT study (Investigating the Management, Perspectives, and Attitudes towards Care in Takayasu Arteritis). This is an anonymous questionnaire-based …

“My world has shrunk” is the title of a mixed-methods exploration of the impact of systemic autoimmune rheumatic diseases on patients’ lives, which is the subject of an article in …

RAIRDA have produced a newsletter giving an update on their recent work, including their comments on the government’s proposed 10-year Health Plan for England.

The National Institute for Health and Care Excellence (NICE) has issued its final draft guidance recommending benralizumab as a treatment option for people with eosinophilic granulomatosis with polyangiitis (EGPA). This …